• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dragonfly Energy and Bruker Partner to Accelerate Battery Technology Development

    11/12/24 7:00:00 AM ET
    $BRKR
    $DFLI
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Industrial Machinery/Components
    Miscellaneous
    Get the next $BRKR alert in real time by email
    • This strategic partnership leverages the complementary strengths of Dragonfly Energy and Bruker, bringing Dragonfly Energy's thorough expertise in liquid and solid-state battery technology together with Bruker's comprehensive suite of analytical solutions for battery research, development and manufacturing
    • The collaboration provides a path toward improving Dragonfly Energy's current and next-generation battery technologies and analytical testing methods using Bruker equipment and analytical expert knowledge
    • Bruker's involvement greatly enhances Dragonfly Energy's in-depth scientific understanding of batteries and battery materials through advanced analytical methods based on magnetic resonance
    • Bruker greatly benefits from Dragonfly Energy's insights into the battery industry including requirements for future states of analytical testing landscapes
    • The collaboration demonstrates Dragonfly Energy's commitment to advancing next-generation battery technologies and Bruker's commitment to providing the battery industry value added R&D toolkits and turn-key solutions for manufacturing affiliated environments

    RENO, Nev., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) ("Dragonfly Energy" or the "Company"), an industry leader in energy storage and maker of Battle Born Batteries®, announced today it has signed a Memorandum of Understanding (MOU) with Bruker (NASDAQ:BRKR), a leader in analytical instrumentation and method development and manufacturing, to collaborate and significantly improve current and next-generation battery technology and battery materials. This strategic partnership leverages the complementary strengths of each company, bringing Dragonfly Energy's thorough expertise in liquid and solid-state battery technology together with Bruker's comprehensive suite of analytical solutions for battery research, development, and manufacturing. This collaboration enhances Dragonfly Energy's scientific understanding of batteries and advanced battery materials through Bruker's cutting-edge magnetic resonance methods, driving advancements in battery technology and sustainable manufacturing processes and the development of next-generation batteries

    "To stay at the forefront of technology and energy storage, our experts need the best tools available, and Bruker provides them," said Dr. Vick Singh, SVP of Technology at Dragonfly Energy. "Partnering with Bruker equips our team for success and drives us toward innovative energy storage solutions, ultimately facilitating our mission of widespread deployment of cost-effective energy storage both on and off the grid."

    Dragonfly Energy uses Bruker's nuclear magnetic resonance ("NMR")-based equipment to study lithium batteries at a fundamental level. Through NMR, battery scientists can pull electrolyte samples at various points during the lifetime of a battery for multiple measurements, helping to optimize the performance of cells produced using the Company's patented dry electrode process. Numerous technologies among Bruker's extensive product portfolio have been utilized in Dragonfly's advancements with lithium battery cells, including AFM, FT-IR, NMR, Raman, XRD, and XRF, among others.

    "We are looking forward to an ongoing partnership with Dragonfly Energy as together we continue to drive battery technology forward," said Dr. Joerg Koehler, Senior Director of Cleantech, Industrial, and Applied Markets at Bruker. "Combining the most advanced analytical instrumentation with lab automation and modern robotics streamlines the connectivity to new and existing workflows at R&D and manufacturing. Bruker's unique software solutions for analytical data interpretation enhance method harmonization and result comparability throughout global organizations. Finally, the connectivity to IoT and data management layers ensures the dataflow and supports evidence-based decision making for efficiency optimized manufacturing. Leveraging both key areas of expertise, battery cell chemistry and analytical solution development we believe will ultimately redefine renewable energy storage."

    For more information about Dragonfly Energy, visit DragonflyEnergy.com. To learn more about Bruker, visit Bruker.com.

    About Dragonfly Energy

    Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) is a comprehensive lithium battery technology company, specializing in cell manufacturing, battery pack assembly, and full system integration. Through its renowned Battle Born Batteries® brand, Dragonfly Energy has established itself as a frontrunner in the lithium battery industry, with hundreds of thousands of reliable battery packs deployed in the field through top-tier OEMs and a diverse retail customer base. At the forefront of domestic lithium battery cell production, Dragonfly Energy's patented dry electrode manufacturing process can deliver chemistry-agnostic power solutions for a broad spectrum of applications, including energy storage systems, electric vehicles, and consumer electronics. The Company's overarching mission is the future deployment of its proprietary, nonflammable, all-solid-state battery cells.

    To learn more about Dragonfly Energy and its commitment to clean energy advancements, visit www.dragonflyenergy.com/investors.

    About Bruker Corporation (NASDAQ:BRKR)

    Bruker provides a comprehensive suite of advanced analytical solutions tailored for every stage of the battery life cycle, from raw material analysis to recycling and data management. Bruker's high-performance scientific instruments and software applications support research, development, manufacturing, and quality control, delivering critical insights into material properties, structural integrity, and chemical composition. For more information, please visit www.bruker.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical statements of fact and statements regarding the Company's intent, belief, or expectations, including, but not limited to, statements regarding its partnership with Bruker BioSpin, the Company's future results of operations and financial position, planned products and services, business strategy and plans, market size and growth opportunities, competitive position and technological and market trends. Some of these forward-looking statements can be identified by the use of forward-looking words, including "may," "should," "expect," "intend," "will," "estimate," "anticipate," "believe," "predict," "plan," "targets," "projects," "could," "would," "continue," "forecast" or the negatives of these terms or variations of them or similar expressions.

    These forward-looking statements are subject to risks, uncertainties, and other factors (some of which are beyond the Company's control) which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Such factors include those set forth in the sections entitled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, and in the Company's subsequent filings with the SEC available at www.sec.gov. If any of these risks materialize or any of the Company's assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that the Company presently does not know or that it currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. All forward-looking statements contained in this press release speak only as of the date they were made. Except to the extent required by law, the Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

    Investor Relations

    Caldwell Bailey

    ICR, Inc.

    [email protected]

    Media Relations

    Amy Demuth, RAD Strategies Inc.

    [email protected]

    Source: Dragonfly Energy Holdings Corp.

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/af5b8794-cbfb-4ec8-b19a-b458f8b1d670



    Primary Logo

    Get the next $BRKR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BRKR
    $DFLI

    CompanyDatePrice TargetRatingAnalyst
    Bruker Corporation
    $BRKR
    12/10/2025$60.00Peer Perform → Outperform
    Wolfe Research
    Bruker Corporation
    $BRKR
    12/9/2025$40.00Sell
    Goldman
    Bruker Corporation
    $BRKR
    11/20/2025$60.00Buy
    Rothschild & Co Redburn
    Bruker Corporation
    $BRKR
    5/22/2025$40.00Buy → Neutral
    Citigroup
    Dragonfly Energy Holdings Corp.
    $DFLI
    3/25/2025$9.00 → $1.50Buy → Neutral
    Alliance Global Partners
    Bruker Corporation
    $BRKR
    12/19/2024$72.00Buy
    Guggenheim
    Bruker Corporation
    $BRKR
    12/10/2024$66.00Neutral
    UBS
    Bruker Corporation
    $BRKR
    12/5/2024$60.00Sell → Neutral
    Goldman
    More analyst ratings

    $BRKR
    $DFLI
    SEC Filings

    View All

    Dragonfly Energy Holdings Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Dragonfly Energy Holdings Corp. (0001847986) (Filer)

    1/30/26 4:10:37 PM ET
    $DFLI
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 424B5 filed by Dragonfly Energy Holdings Corp.

    424B5 - Dragonfly Energy Holdings Corp. (0001847986) (Filer)

    1/30/26 4:05:20 PM ET
    $DFLI
    Industrial Machinery/Components
    Miscellaneous

    Bruker Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - BRUKER CORP (0001109354) (Filer)

    1/12/26 12:00:24 PM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $BRKR
    $DFLI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EXEC VP&PRES BRUKER NANO INC. Munch Mark exercised 2,000 shares at a strike of $22.19 and sold $98,400 worth of shares (2,000 units at $49.20) (SEC Form 4)

    4 - BRUKER CORP (0001109354) (Issuer)

    1/16/26 4:15:05 PM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    EXEC VP&PRES BRUKER NANO INC. Munch Mark exercised 7,000 shares at a strike of $22.19 and sold $385,000 worth of shares (7,000 units at $55.00) (SEC Form 4)

    4 - BRUKER CORP (0001109354) (Issuer)

    1/13/26 4:15:06 PM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 3 filed by new insider Phillips Jack

    3 - BRUKER CORP (0001109354) (Issuer)

    1/9/26 6:19:27 PM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $BRKR
    $DFLI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC

    New iNTApharma system enables rapid, native‑state size and concentration measurements with single‑particle sensitivity for viral, vesicle, and nanoscale bioparticle workflows Bruker Corporation today announced the launch of iNTApharma, a label‑free characterization platform that provides single‑particle sensitivity for the quantitative analysis of nanoscale bioparticles in native aqueous media. Introduced at SLAS 2026 in Boston, iNTApharma delivers size and concentration measurements within minutes, supporting research, therapy development and quality control workflows that require direct, native‑state assessment of bio-nanoparticle populations without labeling or chemical modifications.

    2/9/26 7:00:00 AM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration

    At SLAS2026, Chemspeed Technologies, a leader in the automation and digitalization of R&D and QC laboratories, and SciY, a leader in scientific and laboratory management software focused on lab standardization and AI-readiness, today introduce their open Self‑Driving Lab (SDL) platform. Their Self-Driving Lab platform is designed to accelerate research and development (R&D), quality control (QC) and chemical and biomolecular manufacturing workflows. The SDL enables lab managers to operationalize autonomous, AI‑orchestrated experimentation through vendor‑agnostic integration that unites modular precision automation, scientific analysis and lab management software, complete lab digitization a

    2/9/26 7:00:00 AM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Bruker Announces Quarterly Preferred Stock Dividend

    Bruker Corporation (NASDAQ:BRKR, BRKRP)) today announced that its Board of Directors ("Board") has approved payment of a quarterly cash dividend in the amount of $3.9844 per share on the Company's 6.375% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the "Mandatory Convertible Preferred Stock Dividend"). The Mandatory Convertible Preferred Stock Dividend will be paid on March 2, 2026 to stockholders of record as of February 15, 2026. About Bruker Corporation – Leader of the Post-Genomic Era Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker's hi

    2/5/26 4:05:00 PM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $BRKR
    $DFLI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bruker upgraded by Wolfe Research with a new price target

    Wolfe Research upgraded Bruker from Peer Perform to Outperform and set a new price target of $60.00

    12/10/25 9:02:11 AM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Goldman initiated coverage on Bruker with a new price target

    Goldman initiated coverage of Bruker with a rating of Sell and set a new price target of $40.00

    12/9/25 8:43:14 AM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Rothschild & Co Redburn initiated coverage on Bruker with a new price target

    Rothschild & Co Redburn initiated coverage of Bruker with a rating of Buy and set a new price target of $60.00

    11/20/25 8:06:38 AM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $BRKR
    $DFLI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT & CEO Laukien Frank H bought $100,043 worth of shares (2,608 units at $38.36), increasing direct ownership by 0.01% to 38,462,171 units (SEC Form 4)

    4 - BRUKER CORP (0001109354) (Issuer)

    6/9/25 4:15:11 PM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chief Accounting Officer Bures Thomas bought $23,698 worth of shares (500 units at $47.40), increasing direct ownership by 17% to 3,472 units (SEC Form 4)

    4 - BRUKER CORP (0001109354) (Issuer)

    3/11/25 4:11:27 PM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    PRESIDENT & CEO Laukien Frank H bought $1,018,330 worth of shares (20,000 units at $50.92), increasing direct ownership by 0.05% to 38,459,563 units (SEC Form 4)

    4 - BRUKER CORP (0001109354) (Issuer)

    2/19/25 4:23:26 PM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $BRKR
    $DFLI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Dragonfly Energy Holdings Corp.

    SC 13D/A - Dragonfly Energy Holdings Corp. (0001847986) (Subject)

    11/21/24 6:10:38 PM ET
    $DFLI
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by Bruker Corporation

    SC 13G/A - BRUKER CORP (0001109354) (Subject)

    11/14/24 1:28:29 PM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13G/A filed by Bruker Corporation

    SC 13G/A - BRUKER CORP (0001109354) (Subject)

    11/13/24 6:01:26 PM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $BRKR
    $DFLI
    Leadership Updates

    Live Leadership Updates

    View All

    Solis Agrosciences Names Crystal Winkeler Chief Business Officer to Drive Commercial Growth

    ST. LOUIS, April 23, 2025 (GLOBE NEWSWIRE) -- Solis Agrosciences, the trusted partner for high-quality AgTech research services, announced that it has hired Crystal Winkeler as Chief Business Officer. Winkeler will join Solis on May 1 to drive the company's commercial team and help lead efforts to develop and acquire new offerings. "Solis has assembled an impressive team, offerings, and customer base," said Winkeler. "I am thrilled to join the business at this important growth stage." "Crystal is a proven talent who is confident, capable, and credible in front of customers and stakeholders," said Charlie Bolten, CEO of Solis Agrosciences. "She is a huge addition and will help drive our c

    4/23/25 6:15:00 AM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Bruker Appoints Laura Francis to its Board of Directors

    Bruker Corporation (NASDAQ:BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025. Ms. Francis is also expected to join Bruker's Audit Committee as a financial expert after Bruker's annual shareholder meeting at the end of May 2025. Laura Francis is the Chief Executive Officer and a Board Member of SI-BONE, Inc. (NASDAQ:SIBN), a medical device company solving musculoskeletal disorders of the sacropelvic anatomy. She was previously the Chief Financial Officer and Chief Operating Officer of the company. Prior to joining SI-BONE, Ms. Francis held other executive and leadership roles with

    2/21/25 8:00:00 AM ET
    $BRKR
    $PGNY
    $SIBN
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Misc Health and Biotechnology Services
    Health Care

    Dragonfly Energy Appoints AdvisIRy Partners as its Investor Relations Firm

    RENO, Nev., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) ("Dragonfly Energy" or the "Company"), an industry leader in energy storage and battery technology, today announced it has appointed AdvisIRy Partners as its new investor relations firm. Chief Executive Officer, Dr. Denis Phares, stated, "Dragonfly Energy is an industry leader in providing innovative lithium-ion battery solutions across the RV, trucking, and industrial sectors. The Company is also working to revolutionize next generation battery cell manufacturing with our proprietary dry electrode technology. With Dragonfly Energy at a pivotal point in our evolution, we are pleased to partner with

    2/6/25 7:30:00 AM ET
    $DFLI
    Industrial Machinery/Components
    Miscellaneous

    $BRKR
    $DFLI
    Financials

    Live finance-specific insights

    View All

    Bruker Announces Quarterly Preferred Stock Dividend

    Bruker Corporation (NASDAQ:BRKR, BRKRP)) today announced that its Board of Directors ("Board") has approved payment of a quarterly cash dividend in the amount of $3.9844 per share on the Company's 6.375% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the "Mandatory Convertible Preferred Stock Dividend"). The Mandatory Convertible Preferred Stock Dividend will be paid on March 2, 2026 to stockholders of record as of February 15, 2026. About Bruker Corporation – Leader of the Post-Genomic Era Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker's hi

    2/5/26 4:05:00 PM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast

    Bruker Corporation (NASDAQ:BRKR) today announced it will report fourth quarter and fiscal year 2025 financial results before market opening on Thursday, February 12, 2026. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q4 2025 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-43

    2/5/26 8:00:00 AM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets

    TOFWERK is a profitable innovator in compact, ultra-fast time-of-flight (TOF) mass spectrometry for real-time air and semiconductor cleanroom monitoring, food, flavors & fragrances markets, and FIB-TOF accessories for electron microscopes The ultra-sensitive Vocus™ TOF-MS is customizable for real-time air and cleanroom monitoring applications Microwave-induced plasma (MIP)-TOF systems with atto-to-femtogram detection limits for real-time quantification of trace elements and metals Proprietary flow tube-based VUV CI sources for positive and negative trace organics, inorganics and PFAS contaminants Focused Ion Beam (FIB)-TOF accessories for scanning electron microscopes Bruker

    1/8/26 7:00:00 AM ET
    $BRKR
    Biotechnology: Laboratory Analytical Instruments
    Industrials